三生国健: 三生国健：关于2025年第二次临时股东大会增加临时提案的公告

Group 1 - The company announced an increase in temporary proposals for the 2025 Second Extraordinary General Meeting of Shareholders, which is scheduled for June 5, 2025 [1][2] - The shareholder, Fujian Pharmaceutical Co., Ltd., holding 35.92% of the shares, submitted a written proposal to include a resolution regarding the use of surplus funds for temporary liquidity and adjustments to the investment amounts of certain fundraising projects [2][3] - The original agenda for the shareholders' meeting remains unchanged, and the meeting will take place at the company's conference room in Shanghai [2][3] Group 2 - The network voting system for the shareholders' meeting will be conducted through the Shanghai Stock Exchange's online voting system, with voting available on the same day as the meeting [2][3] - The equity registration date for the shareholders' meeting remains unchanged [3] - The company has provided details regarding the voting rights and types of shareholders eligible to vote on the proposals [6][7]